Anna Sherwood

2.5k citations
23 papers · 1.6k indexed · h-index 16
Topics
T-cell and B-cell Immunology (12 papers)Immune Cell Function and Interaction (9 papers)CAR-T cell therapy research (8 papers)

In The Last Decade

Anna Sherwood

23 papers receiving 1.6k citations

Peers

Anna Sherwood
Comparison fields: 5 of 81
  • Immunology 981
  • Oncology 585
  • Molecular Biology 380
  • Hematology 175
  • Pathology and Forensic Medicine 163
Replace Ivan V. Zvyagin with:
Ivan V. Zvyagin Russia
Randall Armstrong United States
Beatriz Martín-Antonio Spain
Carol E. Schrader United States
Amanda Light Australia
C K Goldman United States
Christiane Werner‐Favre Switzerland
Birgit Knoechel United States
Laurence Ménard United States
Jill Brooks United Kingdom
Anna Sherwood relative to Ivan V. Zvyagin Russia Ivan V. Zvyagin's profile →
Citations per field
00.5×1.5×2.2×
Ivan V. Zvyagin · 1×
Citations per year

Countries citing papers authored by Anna Sherwood

Since Specialization
Citations

This map shows the geographic impact of Anna Sherwood's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Sherwood with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Sherwood more than expected).

Fields of papers citing papers by Anna Sherwood

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Sherwood. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Sherwood. The network helps show where Anna Sherwood may publish in the future.

Co-authorship network of co-authors of Anna Sherwood

This figure shows the co-authorship network connecting the top 25 collaborators of Anna Sherwood. A scholar is included among the top collaborators of Anna Sherwood based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Sherwood. Anna Sherwood is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 35
2 26
3 80
4 37
5 153
6 106
7 24
8 1
9 2
10 131
11 49
12 359
13 1
14 1
15 176
16 103
17 9
18 88
19 39
20 51

About Anna Sherwood

Anna Sherwood is a scholar working on Immunology, Oncology and Hematology, having authored 23 papers that have together received 1.6k indexed citations. Recurring topics across this work include T-cell and B-cell Immunology (12 papers), Immune Cell Function and Interaction (9 papers) and CAR-T cell therapy research (8 papers). The work is most often cited by research in Immunology (981 citations), Oncology (585 citations) and Hematology (175 citations). Anna Sherwood has collaborated with scholars based in United States, South Africa and United Kingdom. Frequent co-authors include Harlan Robins, Ryan Emerson, Christopher S. Carlson, Mark J. Rieder, David Williamson, Cindy Desmarais, David Wu, Brent L. Wood, Robert Livingston and Marissa Vignali. Their work appears in journals such as Nature Communications, Journal of Clinical Oncology and Blood.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026